Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VTGN compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
VTGN
Vistagen Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
VTGN
Vistagen Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
VTGN
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Aug 14 '26
±80.3%
▲
+0.49%
×0.01
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 29 '26
±5.1%
▲
+6.63%
×1.29
Aug 5 '26
±6.2%
▲
+4.86%
×0.79
= implied
VTGN realized, solid
LLY realized, hatched
One scale, both sides: full bar = 81%
× = |realized| ÷ implied
Source: market data
Apr 30 '26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
VTGN
Vistagen Therapeutics, Inc.
Change
0.17
· pre 0.16
· delayed
Mkt cap
$8.2M
Revenue
$1M
Q1 FY27
Revenue
$1M
FY26
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,343.68
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
VTGN
Vistagen Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
0.17
pre 0.16
delayed
Price
1,371.32
pre 1,343.68
delayed
$8.2M
Mkt cap
$1.2T
Q1 FY27
$1M
Revenue
$24.4B
Q3 FY26
FY26
$1M
Revenue
$65.2B
FY25
Change
Change
VTGN
0.17
vs
LLY
1,371.32
Pre-market
Nov 6 '26
delayed